APA (7th ed.) Citation

Lippert, C., Soder, M., Sihler, S., Braun, K., Voegele, J., Wiesel, M., & Staehler, G. (2003). Thrombocytopenia — A new challenge in urooncology: Incidence and clinical implications of hematotoxicities in the chemotherapy with gemcitabine(G)/cisplatin(C) in stage IV bladder cancer. European Urology Supplements, 2(1), 127. https://doi.org/10.1016/s1569-9056(03)80502-x

Chicago Style (17th ed.) Citation

Lippert, C., M. Soder, S. Sihler, K. Braun, J. Voegele, M. Wiesel, and G. Staehler. "Thrombocytopenia — A New Challenge in Urooncology: Incidence and Clinical Implications of Hematotoxicities in the Chemotherapy with Gemcitabine(G)/cisplatin(C) in Stage IV Bladder Cancer." European Urology Supplements 2, no. 1 (2003): 127. https://doi.org/10.1016/s1569-9056(03)80502-x.

MLA (9th ed.) Citation

Lippert, C., et al. "Thrombocytopenia — A New Challenge in Urooncology: Incidence and Clinical Implications of Hematotoxicities in the Chemotherapy with Gemcitabine(G)/cisplatin(C) in Stage IV Bladder Cancer." European Urology Supplements, vol. 2, no. 1, 2003, p. 127, https://doi.org/10.1016/s1569-9056(03)80502-x.